Investments in Finnish biotech
Kuipio/Helsinki – Two Finnish biotech companies have succeed in attracting investments of several million euros. Brain diagnostics firm Nexstim Ltd, whichbased in Helsinki, has announced an €8 million financing round with LSP (Life Sciences Partners) as main investor. The round also included new investors Healthcap and Finnish Industry Investment Ltd. Jurilab Oy, a company spezialised in the discovery of gene-disease associations for several indications (diabetes, obesity), has closed a deal with DSM Venturing, the corporate venturing unit of Royal DSM N.V. The Dutch have made an equity investments of €2 million in the Finnish company which is aimed at fostering their engagement with nutrigenomics.